Who can take part?
By taking part in the A16 Study you would be helping us in our mission to find a way to diagnose Alzheimer’s disease faster. The A16 Study is being carried out to see if our investigational imaging dye (known as a tracer) might be able to help diagnose Alzheimer’s disease faster.
You don’t have to have Alzheimer’s disease to take part. We are looking for people who are:
- At least 50 years old
- Nearing the end of life
- Willing and able to get a PET brain scan
- Would be willing to let us examine your brain after death
Contact Us to Learn More: 1-844-947-6900
About the A16 Study
In people with Alzheimer’s, a protein called ‘tau’ builds up in the brain.
Up until recently, this protein could only be detected by viewing a small piece of the brain under a microscope after death.
But our researchers believe they may be able to detect tau using an investigational imaging dye (known as a ‘tracer’).
Our tracer has been developed to attach to tau in the brain and be highlighted during a brain scan.
As this can be done while the patient is alive, the tracer may help us diagnose Alzheimer’s faster and therefore begin treatment sooner.
To find out if we’re right, we must conduct a clinical research study to compare this new potential method of detecting tau (using a tracer), to the original method (examining the brain under a microscope after death), to check they match up.
And we need people with Alzheimer’s and people without Alzheimer’s to take part.